Jupiter Neurosciences Inc [NASDAQ: JUNS] price plunged by -33.95 percent to reach at -$1.84.
The one-year JUNS stock forecast points to a potential upside of 88.07. The average equity rating for JUNS stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Jupiter Neurosciences Inc [JUNS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JUNS shares is $30.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JUNS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JUNS Stock Performance Analysis:
Jupiter Neurosciences Inc [JUNS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -39.93.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JUNS stock in for the last two-week period is set at 36.68, with the RSI for the last a single of trading hit 27.04, and the three-weeks RSI is set at 43.45 for Jupiter Neurosciences Inc [JUNS]. The present Moving Average recorded at 4.61 for the last single week of trading.
Insight into Jupiter Neurosciences Inc Fundamentals:
Jupiter Neurosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.00 and a Current Ratio set at 0.00.
